Heparin oligosaccharides as potential therapeutic agents in senile dementia - Test2 - elhamkhani - TriplyDB

Heparin oligosaccharides as potential therapeutic agents in senile dementia

Heparin oligosaccharides as potential therapeutic agents in senile dementia

http://www.wikidata.org/entity/Q33965772

about

Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals.Amyloid precursor protein modulates Nav1.6 sodium channel currents through a Go-coupled JNK pathway.Heparan sulfate-protein binding specificity.New Applications of Heparin and Other Glycosaminoglycans.Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid Fibrils Modelling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells.Inhibiting, promoting, and preserving stability of functional proteinfibrils

P2860

Q28269903-22B963A0-BA78-4CA4-BC0B-4E588AF34A2B Q35653704-6F66B26C-77B9-4367-AC0A-3E55CECF64A6 Q37529350-FC07AB0C-09AD-46A7-9D4B-AC9DCD4DBCDD Q38134808-51BF6B6C-767E-4432-8B1E-6917AFBBE7E6 Q39290481-560F32FF-25CB-472B-BA97-B235EBE35709 Q41301732-107D2652-A5AD-4D8B-8F28-879953BE63AD Q47844178-A11EBAF6-56D3-4A55-B084-0750CED73193 Q57364071-4B01E84C-4031-4088-95A8-8B6740D503A7

P2860

Heparin oligosaccharides as potential therapeutic agents in senile dementia

http://www.wikidata.org/entity/Q33965772

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@ast

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@en

type

label

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@ast

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@en

prefLabel

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@ast

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@en

P1433

Q33965772-3FD4F89B-E788-4809-B145-3743EA736E6E

P1476

Q33965772-1535F8AF-8FFF-4841-AD78-BA82DD2EE411

P2093

Q33965772-3479BB61-0983-4C14-9398-D3E162A23595

Q33965772-465B602E-C4B0-4CCF-B6CF-CC636CE59355

Q33965772-717F13C2-2915-4868-BE3D-36E38A6C4480

Q33965772-AF8B2B51-CBB7-4D7E-8C3E-93DA8BF3CFE9

Q33965772-D53792E3-9C6D-4673-A849-3C345DD69A4E

Q33965772-EFECA8D6-5A6C-4DE8-AC4A-DD2AD8C1F2DE

Q33965772-F2E60B03-6FD0-456B-A4F8-4C234B31206D

P2860

Q33965772-10509972-AE03-41A9-9EA9-657E3A0250DD

Q33965772-139849A0-879B-459E-91B5-ACFEF2E31261

Q33965772-13D10327-35C6-463B-B614-CEF01AFACC7B

Q33965772-165A5FAC-9487-4BB8-AB25-9FF2DCA1BEA0

Q33965772-17176853-570C-4422-A862-258743933D3F

Q33965772-19D34722-236F-43E8-86EB-1B39AF58DA3B

Q33965772-1ACC5CF7-E3F1-4E2F-914E-322B021A8836

Q33965772-1AD81B5A-347F-4186-9832-C2069AFBD7C9

Q33965772-1C83EA3E-6FB2-4BA1-A472-EFDCAE62EFD6

Q33965772-20424803-6D56-4774-BECC-5523BA7CFCDF

P304

Q33965772-D5DDB072-56FD-4A7F-BB47-F643FC9B361C

P31

Q33965772-482FC927-CC71-45B5-AAC9-F7C7DED2038C

P356

Q33965772-F637F175-BACA-4E93-8C3E-B9775A7F7FAF

P433

Q33965772-F4E847E8-9A45-49B3-9CE3-A068E0D33658

P478

Q33965772-349BA575-433E-42DE-906C-311A7CEBAF72

P50

Q33965772-B6B5B82C-65D0-427F-8238-BF0F6B447B69

P577

Q33965772-437D5C0B-8FF9-43E4-9A1B-20688810F0B5

P5875

Q33965772-18291955-B799-4A51-BA8F-C24528528D41

P698

Q33965772-761ACB4D-D6DD-4493-8ACB-8A835E0273FA

P921

Q33965772-3B962D4F-1ED0-4E15-A27C-FCE55578AF28

P932

Q33965772-45B276EF-7F4A-4F4C-823D-552CE71EA0AC

P356

138161207780765918

P1433

Current Pharmaceutical Design

P1476

Heparin oligosaccharides as potential therapeutic agents in senile dementia

@en

P2093

Israel Hanin

http://www.w3.org/2001/XMLSchema#string

Jawed Fareed

http://www.w3.org/2001/XMLSchema#string

Jeanine M Walenga

http://www.w3.org/2001/XMLSchema#string

John M Lee

http://www.w3.org/2001/XMLSchema#string

Qing Ma

http://www.w3.org/2001/XMLSchema#string

Umberto Cornelli

http://www.w3.org/2001/XMLSchema#string

Walter P Jeske

http://www.w3.org/2001/XMLSchema#string

P2860

Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes

Inflammation and Alzheimer's disease

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease

The serpin superfamily of proteinase inhibitors: structure, function, and regulation

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

P304

1607-1616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/138161207780765918

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Robert J. Linhardt

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6328501

http://www.w3.org/2001/XMLSchema#string

P698

17504153

http://www.w3.org/2001/XMLSchema#string

P921

oligosaccharide

P932

4114250

http://www.w3.org/2001/XMLSchema#string